TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
70.78
-5.74 (-7.50%)
At close: Oct 16, 2026, 4:00 PM EDT
70.54
-0.24 (-0.34%)
After-hours: Oct 16, 2026, 7:56 PM EDT
TransMedics Group Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $98.73. The average 1-year stock price forecast is 39.49% higher than the current stock price, while the lowest is $65 (-8.17%) and the highest is $125 (+76.60%).
Price Target: $98.73 (+39.49%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $65 | Hold | Maintains | $65 | -8.17% | Oct 15, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $95 → $94 | Buy | Maintains | $95 → $94 | +32.81% | Oct 13, 2026 |
| Barclays | Barclays | Buy Initiates $120 | Buy | Initiates | $120 | +69.54% | Oct 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 | Buy | Maintains | $100 | +41.28% | Oct 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $120 | Buy | Maintains | $120 | +69.54% | Oct 2, 2026 |
Financial Forecast
Revenue This Year
742.18M
from 605.49M
Increased by 22.57%
Revenue Next Year
874.68M
from 742.18M
Increased by 17.85%
EPS This Year
1.51
from 2.63
Decreased by -42.41%
EPS Next Year
2.25
from 1.51
Increased by 48.99%
EPS and Forward PE are based on non-GAAP adjusted numbers.